Trial Profile
Soliris to Stop Immune Mediated Death In Covid 19 Infected Patients. A Trial of Distal Complement Inhibition
Status:
Recruiting
Phase of Trial:
Clinical Phase Unknown
Latest Information Update: 01 Apr 2020
Price :
$35
*
At a glance
- Drugs Eculizumab (Primary)
- Indications COVID 2019 infections
- Focus Expanded access; Therapeutic Use
- Acronyms SOLID-C19
- 03 Mar 2020 New trial record